A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
Conditions: Polymyositis; Dermatomyositis Interventions: Drug: KZR-616; Drug: Placebo Sponsor: Kezar Life Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials